Following in the footsteps of blockbuster drugs such as Ozempic and Wegovy—both powered by semaglutide—Mounjaro (approved for ...

Better U’s one-on-one doctor consultations and on-demand chat support ensure you don’t have to navigate your weight loss ...

Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...

The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...

With demand for weight loss injections soaring, Ranvir Singh investigates who gets them and if tighter restrictions on online ...

The much-awaited launch of Mounjaro, an injectable drug used to treat obesity, overweight, and type 2 diabetes, has been ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

My son has been overweight his whole life. He is now obese and is asking if he could take the medicine he sees on TV ...